Back to Search
DENNIS BOURDETTE, MD
MD
Neurology Physician
NPI: 1104831619Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
MD12086(OR)
Research & Publications (20)
Alemtuzumab versus interferon beta-1a in early multiple sclerosis.
PMID 19664362·Curr Neurol Neurosci Rep·2009
8-other
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.
PMID 16193893·Mult Scler·2005
3-trial
Symptom factor analysis, clinical findings, and functional status in a population-based case control study of Gulf War unexplained illness.
PMID 11765674·J Occup Environ Med·2001
8-other
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
PMID 19664372·Curr Neurol Neurosci Rep·2009
6-review
The radiologically isolated syndrome: is it very early multiple sclerosis?
PMID 19073944·Neurology·2009
8-other
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
PMID 18713578·Curr Neurol Neurosci Rep·2008
8-other
Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction.
PMID 18570015·Somatosens Mot Res·2008
8-other
A randomized pilot study of naturopathic medicine in multiple sclerosis.
PMID 18532899·J Altern Complement Med·2008
2-rct
Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.
PMID 18562016·J Neuroimmunol·2008
8-other
Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.
PMID 17944900·Immunology·2008
3-trial
Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS.
PMID 18537699·Endocr Metab Immune Disord Drug Targets·2008
6-review
Lipoic acid stimulates cAMP production in T lymphocytes and NK cells.
PMID 17210133·Biochem Biophys Res Commun·2007
8-other
Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial.
PMID 17439907·Mult Scler·2007
2-rct
Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis.
PMID 17055066·J Neuroimmunol·2007
7-preclinical
Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
PMID 17463082·Proc Natl Acad Sci U S A·2007
7-preclinical
Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck).
PMID 16631599·Biochem Biophys Res Commun·2006
8-other
Complementary and alternative medicine: is there a role in multiple sclerosis?
PMID 16635436·Curr Neurol Neurosci Rep·2006
6-review
Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis.
PMID 16644024·J Neuroimmunol·2006
4-observational
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
PMID 16899071·J Neurochem·2006
7-preclinical
Frequency-modulation (FM) technology as a method for improving speech perception in noise for individuals with multiple sclerosis.
PMID 16999255·J Am Acad Audiol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 494-7772
Quick Facts
- NPI
- 1104831619
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile